Concept and contents by Sonja Duggen and Cordula Klemm
Any suggestions or questions? Tweet us @helmholtzMucEn
The one-day Oktoberfest Symposium is small but exclusive. Clinical researchers and scientists of world renown convene in Munich at the invitation of Helmholtz Zentrum München, Institute of Diabetes Research, the Diabetes Research Group of Technische Universität München and the Diabetes Research Group e.V.
The development, diagnosis and prevention of diabetes type 1 and gestational diabetes are central themes of the Oktoberfest Symposium. The focus of the ninth meeting is the early diagnosis of the disease in children by appropriate markers.
Learn more about Fr1da
Early Diagnosis Helps to Avert Damage Caused by Type 1 DiabetesAt the Oktoberfest Symposium studies for an early diagnosis for type 1 diabetes in children are presented. Four immunological markers are currently being tested in the world's first comprehensive type 1 diabetes screening study Fr1da.
Ezio Bonifacio is professor and group leader at the DFG Center for Regenerative Therapies at Technische Universität Dresden. At Helmholtz Zentrum München he leads the research group “Immunobiology of Diabetes”, which is based at the Institute for Diabetes and Obesity
“At the Oktoberfest Symposium I meet top experts in the field of the biology of type 1 diabetes. The Fr1da and TEDDY studies presented here are very important for an early diagnosis of type 1 diabetes and for a better understanding of the pathogenesis of the disease. From the presentations and discussions, we develop approaches for joint studies and data evaluations, which should make better treatment of the disease possible. ”
Richard Oram is a clinical researcher and teaches at the University of Exeter Medical School. His research activities focus on endogenous insulin production in type 1 diabetes patients.